Rothschild Investment Corp Intercept Pharmaceuticals, Inc. Transaction History

Rothschild Investment Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$58.69 - $80.46 $164,332 - $225,287	-2,800 Closed	0 $0
Q2 2019 Jul 11, 2019	BUY	$77.77 - $120.68 $217,756 - $337,904	2,800 New	2,800 $223,000
Q1 2019 Apr 18, 2019	SELL	$91.83 - $120.68 $182,741 - $240,153	-1,990 Closed	0 $0
Q3 2018 Oct 17, 2018	SELL	$88.49 - $127.55 $221,225 - $318,875	-2,500 Reduced 55.68%	1,990 $251,000
Q2 2018 Jul 24, 2018	SELL	$60.0 - $85.67 $40,440 - $57,741	-674 Reduced 13.05%	4,490 $377,000
Q4 2017 Jan 23, 2018	SELL	$58.2 - $72.76 $39,692 - $49,622	-682 Reduced 11.67%	5,164 $302,000
Q3 2017 Oct 25, 2017	BUY	$57.01 - $118.75 $333,280 - $694,212	5,846	5,846 $339,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

Stay updated on Rothschild Investment Corp with notifications on news.